XTRENBO (Denosumab-qbde)

**Product type:** Human Prescription Drug

**Active ingredient:** DENOSUMAB

**Strength:** 120 mg/1.7mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Hikma Pharmaceuticals USA Inc.

**Marketing category:** BLA (BLA761439)

**Pharmacologic class:** RANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]